AQR Capital Management
USNA icon

AQR Capital Management’s Usana Health Sciences USNA Stock Holding History

AQR Capital Management’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.18M Buy
296,420
+240,218
+427% +$4.77M ﹤0.01% 1720
2025
Q4 		$1.1M Sell
56,202
-19,625
-26% -$407K ﹤0.01% 2491
2025
Q3 		$2.09M Buy
75,827
+61,241
+420% +$1.88M ﹤0.01% 1956
2025
Q2 		$445K Sell
14,586
-7,259
-33% -$206K ﹤0.01% 2683
2025
Q1 		$589K Buy
21,845
+9,894
+83% +$313K ﹤0.01% 2327
2024
Q4 		$429K Buy
11,951
+2,765
+30% +$103K ﹤0.01% 2321
2024
Q3 		$348K Sell
9,186
-2,242
-20% -$92.1K ﹤0.01% 2327
2024
Q2 		$517K Sell
11,428
-3,293
-22% -$151K ﹤0.01% 2039
2024
Q1 		$714K Sell
14,721
-4,559
-24% -$223K ﹤0.01% 1822
2023
Q4 		$1.03M Sell
19,280
-20,158
-51% -$1.02M ﹤0.01% 1594
2023
Q3 		$2.31M Sell
39,438
-8,280
-17% -$518K ﹤0.01% 1263
2023
Q2 		$3.01M Sell
47,718
-4,626
-9% -$295K 0.01% 1110
2023
Q1 		$3.29M Buy
52,344
+4,378
+9% +$261K 0.01% 1059
2022
Q4 		$2.55M Buy
47,966
+17,763
+59% +$962K 0.01% 1158
2022
Q3 		$1.69M Buy
30,203
+13,457
+80% +$890K ﹤0.01% 1277
2022
Q2 		$1.21M Sell
16,746
-3,575
-18% -$266K ﹤0.01% 1332
2022
Q1 		$1.61M Buy
20,321
+395
+2% +$35.6K ﹤0.01% 1312
2021
Q4 		$2.02M Sell
19,926
-9,749
-33% -$972K ﹤0.01% 1163
2021
Q3 		$2.74M Sell
29,675
-4,190
-12% -$403K 0.01% 993
2021
Q2 		$3.47M Sell
33,865
-9,219
-21% -$926K 0.01% 948
2021
Q1 		$4.21M Sell
43,084
-7,351
-15% -$669K 0.01% 872
2020
Q4 		$3.89M Buy
50,435
+897
+2% +$69.4K 0.01% 864
2020
Q3 		$3.65M Buy
49,538
+4,112
+9% +$330K 0.01% 862
2020
Q2 		$3.34M Buy
45,426
+1,465
+3% +$115K 0.01% 935
2020
Q1 		$2.54M Sell
43,961
-85,492
-66% -$5.95M ﹤0.01% 998
2019
Q4 		$10.2M Sell
129,453
-53,730
-29% -$3.96M 0.01% 749
2019
Q3 		$12.5M Sell
183,183
-62,903
-26% -$4.22M 0.01% 698
2019
Q2 		$19.5M Sell
246,086
-36,388
-13% -$2.89M 0.02% 601
2019
Q1 		$23.7M Buy
282,474
+9,679
+4% +$1.01M 0.03% 572
2018
Q4 		$32.1M Buy
272,795
+31,781
+13% +$3.67M 0.04% 451
2018
Q3 		$29.1M Buy
241,014
+78,733
+49% +$9.77M 0.03% 507
2018
Q2 		$18.7M Buy
162,281
+87,850
+118% +$9.61M 0.02% 601
2018
Q1 		$6.39M Buy
74,431
+12,730
+21% +$986K 0.01% 910
2017
Q4 		$4.57M Sell
61,701
-3,967
-6% -$265K ﹤0.01% 1066
2017
Q3 		$3.79M Buy
65,668
+20,987
+47% +$1.24M ﹤0.01% 1138
2017
Q2 		$2.86M Buy
44,681
+2,533
+6% +$156K ﹤0.01% 1244
2017
Q1 		$2.43M Sell
42,148
-9,876
-19% -$590K ﹤0.01% 1301
2016
Q4 		$3.18M Sell
52,024
-14,396
-22% -$938K ﹤0.01% 1215
2016
Q3 		$4.59M Sell
66,420
-23,044
-26% -$1.52M 0.01% 1038
2016
Q2 		$4.98M Sell
89,464
-16,508
-16% -$995K 0.01% 916
2016
Q1 		$6.43M Buy
105,972
+26,432
+33% +$1.56M 0.01% 806
2015
Q4 		$5.08M Sell
79,540
-25,724
-24% -$1.67M 0.01% 907
2015
Q3 		$7.05M Sell
105,264
-40,104
-28% -$2.84M 0.01% 699
2015
Q2 		$9.93M Sell
145,368
-5,354
-4% -$340K 0.02% 613
2015
Q1 		$8.37M Buy
150,722
+62,734
+71% +$3.22M 0.02% 598
2014
Q4 		$4.51M Buy
87,988
+53,080
+152% +$2.61M 0.01% 947
2014
Q3 		$1.29M Sell
34,908
-42,400
-55% -$1.53M ﹤0.01% 1488
2014
Q2 		$3.02M Sell
77,308
-115,800
-60% -$4.3M 0.01% 1105
2014
Q1 		$7.27M Buy
193,108
+600
+0.3% +$21K 0.02% 704
2013
Q4 		$7.28M Buy
192,508
+11,650
+6% +$446K 0.02% 710
2013
Q3 		$7.85M Sell
180,858
-68,136
-27% -$2.73M 0.03% 650
2013
Q2 		$9.01M Buy
+248,994
New +$7.57M 0.03% 607

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management's USNA Position: Q1 2026 in Review

AQR Capital Management increased its Usana Health Sciences (USNA) stake by 427% in Q1 2026, buying an estimated $4.77M and bringing the position to 296,420 shares worth $5.18M. The position accounts for ﹤0.01% of the portfolio, ranked #1720.

AQR Capital Management first reported a position in USNA in Q2 2013 and has held it in 52 quarters since. The position peaked at $32.1M in Q4 2018. 139 funds tracked by Wall St. Rank hold USNA as of Q1 2026.

  • AQR Capital Management held 296,420 shares of Usana Health Sciences worth $5.18M as of Q1 2026.
  • AQR Capital Management bought 240,218 Usana Health Sciences shares in Q1 2026, an estimated $4.77M.
  • Usana Health Sciences made up ﹤0.01% of AQR Capital Management's portfolio in Q1 2026, its #1720 holding.
  • AQR Capital Management first reported a position in Usana Health Sciences in Q2 2013 and has held it in 52 quarters since.
  • AQR Capital Management's Usana Health Sciences position peaked at $32.1M in Q4 2018.
  • 139 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.